Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06685783 · ClinicalTrials.gov registry record

Vis-Rx Prime Micro-Imaging Catheter Study

A clinical trial of Coronary Artery Disease, sponsored by Gentuity.

Active
Registry status
70
Enrollment target
3
Study locations

NCT06685783: Active study of Coronary Artery Disease, sponsored by Gentuity.

NCT06685783 is a study of Coronary Artery Disease that is active but no longer recruiting, run by Gentuity. The registered enrollment target is 70 participants, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (95% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06685783, a study of Coronary Artery Disease, is active but no longer recruiting, sponsored by Gentuity.

ACTIVE NOT RECRUITING
Registry status
70 participants
Enrollment target
3
Study locations

Study Summary

To study the performance of the Gentuity® HF-OCT Imaging System and Vis-Rx Prime® Micro-Imaging Catheter when used to obtain images of coronary arteries in patients who are undergoing cardiac catheterization and are candidates for interventional procedures. The study will evaluate ease of catheter use by physicians using the catheters, image quality and overall performance. The patient's involvement in the study ends when the cardiac catheterization/interventional procedure is completed.

Primary Outcome

Clear Image Length of the acquired HF-OCT image during each pullback during a percutaneous coronary intervention procedure

Conditions Studied

Coronary Artery Disease

Study Locations (3)

Illinois

  • Advocate Lutheran General Hospital - Park Ridge

New York

  • St. Francis Hospital and Heart Center - Roslyn

Ohio

  • Lindner Research Center at The Christ Hospital - Cincinnati

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2024-12-11
Est. Completion 2026-07
Gentuity

3 total trials

What the registry record for NCT06685783 still lists

NCT06685783 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (95% lower).

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 0 interventions.

NCT06685783 reports a single indexed study location in Illinois, New York, Ohio.

Frequently Asked Questions

What is clinical trial NCT06685783 about?

NCT06685783 is a clinical study titled "Vis-Rx Prime Micro-Imaging Catheter Study". To study the performance of the Gentuity® HF-OCT Imaging System and Vis-Rx Prime® Micro-Imaging Catheter when used to obtain images of coronary arteries in patients who are undergoing cardiac catheterization and are candidates for interventional procedures. The study will evaluate ease of catheter u...

What is the current status of trial NCT06685783?

This trial is currently active not recruiting. The enrollment target is 70 participants. The study started on 2024-12-11. Estimated completion is 2026-07.

What conditions does trial NCT06685783 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

Who is sponsoring clinical trial NCT06685783?

This trial is sponsored by Gentuity, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06685783 being conducted?

This trial has 3 study locations across Illinois, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06685783's enrollment target sits among peer trials

70 165th of 219 higher than 55 of 219 other Coronary Artery Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Coronary Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT06685783, the US trial registry maintained by the National Library of Medicine. NCT06685783 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.